Tirzepatide 50mg Vial
Dual GIP & GLP-1 Receptor Agonist — 50mg Lyophilised Vial
£80.00
1
🇬🇧UK Based & Shipped
99%+ Purity Guaranteed
Discreet, Vacuum-Sealed
Encrypted Checkout
All products include a verification code for authenticity
A dual GIP and GLP-1 receptor agonist — one of the most extensively studied peptides in metabolic research, with landmark SURPASS and SURMOUNT trial data.
- Dual receptor agonist — activates both GIP and GLP-1 pathways simultaneously
- Weight management research — landmark SURMOUNT trial data up to 22.5% body weight reduction
- Glucose regulation — enhances glucose-dependent insulin secretion
- Appetite control — researched for slowing gastric emptying and reducing food intake
- Energy & metabolic balance — studied for improved lipid profile and metabolic markers
- Flexible dosing — multi-dose pen delivers 1–6mg per click for precise research protocols
For Research Purposes Only
This product is supplied strictly for research and laboratory use only. Not intended for human consumption. Not for medical use. Not intended to diagnose, treat, cure, or prevent any disease.